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Intrudction
H
epatitis  C  virus  (HCV)  often  causes  a 
prolonged  and  persistent  infection  and  is 
associated  with  hepatocellular  carcinoma  (HCC) 
(1,  2). The  pathogenesis  of  liver  damage  is  at  least 
in  part  related  to  viral  protein-mediated  factors. 
Understanding  the  molecular  basis  of  pathogenesis 
is a major challenge in gaining insight into HCV-
associated  disease  progression.  Recent  experimental 
evidence using HCV-cloned genomic regions suggests 
that  the  genotype  1b  HCV  core  protein  (HCV 
Core) has numerous functional activities (3, 4). These 
include HCV Core’s likely role in regulatory effects 
on cellular and unrelated viral promoters, interactions 
with a number of cellular proteins, a modulatory role 
in programmed cell death or apoptosis under certain 
conditions,  involvement  in  cell-growth  promotion 
and immortalization, induction of HCC in transgenic 
mice, and a possible immunoregulatory role. These 
intriguing  properties  suggest  that  HCV  Core  may 
contribute to pathogenesis during persistent infection 
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Background and Aims: Because hepatitis C virus (HCV) core protein (Core), protein kinase R (PKR), and signal transducer 
and activator of transcription 3 (STAT3) all play relevant roles in the pathogenesis of HCV, persistent infection and 
hepatocellular carcinoma (HCC) and PKR may interact with HCV Core. In this study, we further investigate the associations 
among HCV Core, PKR, and STAT3 and the mechanisms involved in these interactions. 
Materials and Methods: Expression levels of HCV Core, PKR, eukaryotic initiation factor 2 (eIF-2α), phosphorylated eIF-
2α (p-eIF-2α), STAT3, and phosphorylated-STAT3 (p-STAT3) were compared between Huh-7 and replicon cell-Huh-7 
cells harboring the full length of genotype 1b HCV genomes. Co-immunoprecipitation and glutathione S-transferase 
(GST) pull-down assay were conducted for HCV Core, PKR, and STAT3. 
Results: HCV may have induced the expression of STAT3 and the activity of PKR (p-eIF-2α). HCV Core, STAT3, and 
PKR appear to have interacted with one another. The N-terminal 1-126 amino acid (aa) of HCV Core contributed to an 
interaction between HCV Core and STAT3, and only full-length PKR bound to STAT3 and p-STAT3. 
Conclusions: These findings suggest that HCV Core, PKR, and STAT3 can interact with each other. Specifically, HCV Core 
may play its role through both PKR and STAT3. Alternatively, HCV Core’s binding to and activation of STAT3 might be due 
to the interaction between HCV Core and PKR. The distinct interactions among these three molecules are important and 
may reveal a new molecular mechanism in the pathogenesis of HCV-persistent infection and HCV-related HCC.
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and HCC, but the exact mechanisms of HCV remains 
unclear (5). Of the many proteins activated by HCV 
replication, both interferon-induced, double-stranded, 
RNA-activated  protein  kinase  R  (PKR)  and  signal 
transducer and activator of transcription 3 (STAT3) 
are the subjects of considerable attention (6-8). PKR 
is  a  key  arm  of  the  antiviral  and  antiproliferative 
effects  of  interferon.  PKR  binds  to  dsRNA, 
resulting  in  a  conformational  change  that  leads  to 
autophosphorylation on several serine and threonine 
residues.  PKR  then  dimerizes  and  phosphorylates 
serine residue 51 on the alpha-subunit of the eukaryotic 
initiation factor 2 (eIF-2α). Phosphorylated eIF-2α 
(p-eIF-2α) inhibits translation initiation and decreases 
the rate of protein synthesis (6, 7). STAT-family proteins 
are transcription factors critical in mediating cellular 
signalling. Among them, STAT3 is often constitutively 
phosphorylated  (p-STAT3)  in  human  cancers  and 
implicated in tumorigenesis. Constitutive activation 
of STAT3 and PKR have been demonstrated to be 
associated with malignant transformation induced by 
various oncoprotein. Different domains of PKR and 
STAT3  might  have  different  functions.  Both  PKR 
and STAT3 affect normal cellular functions, such as 
cell proliferation, death and play an important role in 
cell transformation and tumors (6-8), PKR and STAT3 
are both present in greater number in HCV-derived 
HCC tumor tissue than nontumor tissue (9, 10). PKR 
might be necessary for STAT3 phosphorylation after 
platelet-derived  growth  factor  (PDGF)  stimulation 
(11). Because HCV Core not only binds to and interacts 
with PKR (12) but also cooperates with STAT3 and 
leads to cellular transformation (8), PKR and STAT3 
may therefore contribute to HCV’s viral persistence 
and its association with HCC. Our previous studies 
found that HCV Core can interact with PKR (12) and 
that the interactions might be a general phenomenon, 
regardless  of  HCV  genotype  and  strain.  Based  on 
these findings, we examine whether or not HCV Core 
can directly interact with STAT3, PKR, with STAT3, 
and  the  mechanisms  by  which  these  interactions 
occur. We further demonstrate the direct interactions 
among HCV Core, PKR, and STAT3 and propose 
two models of associations between the three in the 
pathogenesis of persistent HCV and HCC.
Materals And Methods
Plasmid construction 
Different  glutathione--transferase  (GST)  Core 
or Core-truncated fusion proteins were constructed 
using  the  pGEX-4T-1vector.  The  different  core 
sequences were amplified from the pDP18 vector 
containing  tumor  (T)  or  non-tumor  (NT)  Core 
sequences from patient B (BT and BNT) in Delhem 
et al. (6). or HCV core genotype 1b, C191, isolated 
from serum (Figure 1A). The following primers were 
designed according to the different core sequences 
and the various sizes desired. Plasmid construction 
was conducted according to YAN et al.  (12) PCR 
products were cloned at the EcoR-I and BamH-I sites 
in the pGEX-4T-1 vector to obtain various GST-core 
fusion proteins. Full-length and different truncated 
GST-PKR expression plasmids were generous gifts 
from Dr. Meurs (Pasteur Institute, France) according 
to (13) full-length PKR corresponded to amino acids 
A
B
Figure 1. Schematic representation of the open reading frame encoding various truncated Core 
and PKR. A: BT: Core gene from tumor tissue of the patient with HCC caused by HCV; 
BNT: Core gene from non-tumor tissue of the patient with HCC caused by HCV; C191: Core 
gene from genotype 1b, HCV-J6. B: DRBD: double stranded RNA binding domain, KD: kinase 
domain. Functional domains are shown in shadowed boxes along the diagrams. Results of the 
binding experiments are shown on the right.Hepat Mon. 2010; 10(4): 275-284
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(aa) 1–551, and truncated forms to PKR aa 1–265, 
PKR aa 1–180, and PKR aa 265–551 (Figure 1B).
Cell culture
The human hepatoma cell lines HepG-2 and Huh-
7 were grown in Dulbecco’s modified eagle medium 
(DMEM,  Invitrogen,  France)  supplemented  with 
10% foetal bovine serum (FBS, Invitrogen, France), 
2 mM L-glutamine, 100 U/ml penicillin, 100 μg/ml 
streptomycin, and 2.5 μg/ml plasmocin. Cells from 
the full-length HCV replicon cell line (A kind gift 
from C. Rice, Rockefeller University, New York City, 
USA),  were  cultured  in  DMEM  containing  10% 
FBS, 100 U/ml penicillin, 100 μg/ml streptomycin, 
and G418 250 μg/ml. For the cell-protein extracts, 
about  2×106  cells  were  seeded  in  10-cm  dishes, 
and 24 hours after plating, stimulated with human 
recombinant interferon-alpha-2α 500 U/ml for 18 
hours (R&D Europe, France). Cells were lysed in 
300 μl cell-lysis buffer (20 mM Tris pH 7.8, 150 mM 
NaCl, 0.5 mM EDTA, 0.5 mM PMSF, NP40 0.2%) 
and frozen at -80°C for 15 minutes. Homogenates 
were centrifuged at 12,000 rpm for 5 min. Proteins 
were quantified with a Beckman 600 using the Bio-
Rad protein assay (Bio-Rad, France).
SDS-PAGE and Western blotting
50 μg of total protein, co-immunoprecipitation, 
and GST pull-down assay elution buffer were loaded 
onto  an  SDS  10%  polyacrylamid  gel,  transferred 
onto  a  0.22-nm  nitrocellulose  membrane,  and 
blotted using different first antibodies: anti-STAT3, 
anti-p-STAT3,  anti-PKR,  anti-eIF-2α,  anti-p-eIF-
2α  (1/1000:  Santa  Cruz,  Biotechnology,  USA), 
anti-HCV Core, and second antibodies. Blots were 
incubated  with  the  peroxydase-coupled  second 
antibodies  anti-mouse:  1/2000  and  anti-rabbit: 
1/5000 (Amsersham, Pharmacia, USA), and proteins 
were visualized using a chemiluminescence detection 
kit (ECL, Amersham, Pharmacia, USA).
Co-immunoprecipitation analysis
Total proteins of 500 μg were precleared at 4°c for 
1 hour with 20 μl of protein G-sepharose 4 fast-flow 
beads (Amsershan; Biosciences) and then centrifuged 
at  15,000  rpm  for  5  minutes.  After  preclearing, 
the  supernatant  was  incubated  in  cell-lysis  buffer 
overnight at 4°c under gentle rotation with polyclonal 
anti-PKR (1/100), anti-STAT3 (1/300), and 30 μl 
of protein G. The beads were washed 3 times with 
TBS buffer (50 mmol/L Tris pH 7.6, 150 mmol/L 
NaCl, 0.5% triton) and solubilized in 2xSDS-PAGE 
loading  buffer  and  centrifuged  at  1,500  rpm.  As 
described above, the supernatant was subjected to a 
western blot.
Production of GST fusion proteins
GST-core  and  GST-PKR  fusion  proteins  were 
expressed in Escherichia coli BL21 (ED3), harboring 
the  respective  plasmids  as  described  by  Bonnet   
et al.  (14).Cells were grown overnight at 37°C in 
100 ml terrific broth (TB) containing 100 μg/ml of 
ampicillin. A 1/100th volume of overnight culture 
was inoculated in 100 ml fresh medium, grown at 
30°C to an OD of 0.5 at 600 nm and then induced 
with 0.5 mM isopropyl-1-thiod-galactopyranoside 
(IPTG) for exactly 2 hours. Cells were harvested 
by centrifugation at 4,000 rpm for 10 minutes at 
4°C, resuspended in 5 ml prechilled PBS containing 
0.2 mM PMSF and 1 mM DTT, then frozen and 
thawed twice at -80°C. After 4 sonications of 20 
seconds each on ice, Triton X-100 was added at a 
final concentration of 1%. Lysates were centrifuged 
at 9,000 rpm for 20 minutes at 4°C. Supernatants 
(5  ml)  were  incubated  with  250  μl  glutathion-
sepharose-4B beads (Amersham, France) for 1 hour 
at 4°C under gentle rotation. After centrifugation at 
5,000 rpm for 5 min, the beads were washed 4 times 
with PBS and protease inhibitors, suspended in 2.5 
ml  30%  glycerol-PBS  and  stored  at  -80°C.  The 
concentration of GST-fusion proteins was estimated 
by comparison with a known concentration of BSA 
using  SDS-PAGE  with  Coomassie  Blue  Staining 
(Bio-safe, Bio-Rad).
GST pull-down assay
1  μg  of  different  truncated  GST-PKR  fusion 
proteins  were  used  per  pull-down  assay.  GST-4B 
empty beads were used to adjust each reaction system 
with all 30 μl of beads. The beads were incubated 
with 120 μg of protein extraction in a final volume 
of 200 μl of HNGT (20 mmol/L HEPES pH 7,9, 
150  mmol/L  NaCl,  10%  glycerol,  0.1%  Triton 
X-100, 0,2 mmol/L PMSF, 1 mmol/L DTT) buffer 
overnight at 4°C under gentle rotation. Following 
incubation, the reaction mixtures were centrifuged 
at 1,500 rpm for 5 minutes at 4°C and washed 5 
times with 1 ml of cold binding buffer of HNGT. 
After a final wash, proteins bound to the beads were 
eluted by boiling in a 2×SDS-PAGE sample buffer. 
After centrifugation, the supernatants were subjected 
to SDS-PAGE and immunoblotted. 
Results
HCV increases the expression levels of STAT3 and 
p-eIF-2α
We first conducted a western blot to find if all 
HCV proteins were expressed in replicon cells (Huh-
7  cell  line  harboring  selective  full-length  of  HCV Hepat Mon. 2010; 10(4): 275-284
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genomic). As shown in figure 2, structure protein E2, 
HCV Core, and nonstructure protein NS3 of HCV 
were all expressed in replicon cells. After stimulation 
with IFN-α, levels of E2, HCV Core, and NS3 were 
decreased, which indicated that IFN-α could suppress 
the replication of replicon cells and expression of E2, 
HCV Core, and NS3. Then replicon cells and Huh-
7 cells were used to observe if HCV could affect the 
expression of STAT3, p-STAT3, PKR, eIF-2α, and 
p-eIF-2α,  respectively.  eIF-2α  and  p-eIF-2α  were 
markers  of  PKR  activity.  Stimulation  with  IFN-α 
resulted in an increase in the induction of PKR and 
STAT3 in both Huh-7 and replicon (Figures 3A and 
3C, lanes 2 and 4 to lanes 1 and 3, respectively), but 
without change in the level of p-STAT3, eIF-2α and 
p-eIF-2α (Figures 3B, 3D, and 3E). Both with and 
without  IFN-α  stimulation  STAT3  and  p-eIF-2α 
is higher in replicon compared with Huh-7 (Figure 
3E, lanes 3 and 4 to lanes 1 and 2), but there is no 
difference  in  p-STAT3,  PKR,  and  eIF-2α  between 
Huh-7 and replicon both with and without IFN-α 
stimulation (Figures 3B, 3C, and 3D, lane 1 and 2 to 
lane 3 and 4), which suggests that HCV could affect 
the STAT3 expression and activity of PKR, but not 
the expression levels of PKR and p-STAT3. The results 
were further confirmed by next experiment with PKR, 
STAT3, and p-STAT3 (Figures 7C, 7D, and 7E).
HCV Core induces the expression of STAT3
As  shown  above,  HCV  could  increase  the 
STAT3 expression and activity of PKR, but not the 
expression  levels  of  PKR  and  p-STAT3.  Because 
replicon cells can express E2, HCV Core, and NS3, 
we  conducted  another  experiment  to  investigate 
whether HCV Core could increase the expression 
of STAT3 and PKR. In the same cell line (Huh-
7),  Huh-7  transfected  with  plasmid  containing 
HCV Core (C191) and Huh-7 harboring selective 
full-length HCV genome (replicon), and different 
expression levels of STAT3 were found (Figure 4). 
The level of STAT3 in transfected cells was higher 
compared with the levels in Huh-7 and replicon, and 
the STAT3 level in replicon was higher than that of 
Huh-7; however, there was no obvious difference in 
p-STAT3 among them. These findings indicate that 
HCV could affect the STAT3 expression, mainly due 
to HCV Core. In a previous study, we found that 
HCV Core could increase the activity of PKR (6, 12).
HCV Core physically interacts with STAT3
To  determine  whether  STAT3  is  present  in  a 
complex with HCV Core, a co-immunoprecipitation 
assay  was  performed  with  anti-STAT3  polyclonal 
antibody. The results indicated that HCV Core and 
STAT3 were physically associated (Figure 5). This 
specific interaction between HCV Core and STAT3 
was further demonstrated by in vitro GST pull-down 
(Figures 6B, 7A, and 7B). GST fused to the HCV 
Core 1-172 amino acid (aa) of BT, BNT, and C191 
(but not the control GST), and clearly pulled down 
in vitro-expressed STAT3 in different cells (Huh-7, 
replicon; Figure 6B). These results strongly suggest 
that HCV Core forms a complex with STAT3. 
The N-terminus of HCV Core aa 1-126 including 
the two fragments 1-58 aa and 59-126 aa is involved 
in the interaction with STAT3
In order to map which domain was responsible 
for the HCV Core/STAT3 and HCV Core/p-STAT3 
Figure 2. Expression levels of different HCV 
proteins  induced  with  IFN-α.  Using  western 
blot analysis, different proteins including Core, 
E2 and NS3 were expressed in Replicon cell. 
Expression levels of the different proteins were 
suppressed after IFN-α stimulation. 50, 100 stand 
for input of 50 μg and 100 μg cell protein.
 1     2     3     4
Figure  3.  HCV  induced  the  expression  of  STAT3, 
p-STAT3, PKR, eIF-2α and p-eIF-2α 50 μg of total cell 
extract was used to western blot. Cells were treated with 
IFN-α 500 IU/ml for 18 hours. Stimulation with IFN-α 
increased the expression level of STAT3 and PKR in 
both Huh-7 and replicon (Figure.2: A, C: lane 2, 4 to 
lane 1, 3), but without change in the level of p-STAT3, 
eIF-2α and p-eIF-2α (Figure.2: B, D, E). Both with and 
without IFN-α stimulation STAT3 and p-eIF-2α is higher 
in replicon compared with in Huh-7 (Figure.2: E lane 
3,4 to lane 1,2), but there is no difference in p-STAT3, 
PKR and eIF-2α between Huh-7 and replicon both with 
and without IFN-α stimulation (Figure.2: A, B, C, D: lane 
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interactions, a GST pull-down assay was performed. 
As shown in figure 6B, there was no binding band in 
lane 1 (GST), suggesting that the HCV Core/STAT3 
binding was specific. GST-Core 1-58, GST-Core 59-
126, GST-Core 1-126, and GST-Core 1-172 (BT, 
BNT, C191), but not the control GST (GST-Core 
127-172), expressed STAT3 when pulled down in 
vitro. These results suggest that the smallest binding 
domains are 1-58 aa and 59-126 aa of HCV Core. 
The binding affinity decreased as the fusion proteins 
(BT: 1-172 aa, 1-126 aa, 1-58 aa, 59-126 aa) became 
shorter, which indicates that the neighboring flanking 
region of N-terminal 1-58 aa and 59-126 aa might 
also contribute to efficient binding or that one of the 
two fragments enhances the other’s binding affinity. 
There is some difference of HCV Core/STAT3 and 
HCV  Core/p-STAT3  binding  affinity  among  the 
different HCV strains with the same length 1-172 
aa (BT, BNT, C191). The binding between HCV 
Core from BT and STAT3 (Figure 6B, lane 2) is 
stronger than that the binding between HCV Core 
from BNT and C191 (Figure 6B and 6C, lanes 7 
and 8), and only HCV Core from BT can bind to 
p-STAT3 (Figure 6C). The result was further verified 
by repeating the experiment (Figure 7).
PKR  physically  interacts  with  STAT3  and  only 
full-length PKR binds with STAT3 and p-STAT3
To determine the region of PKR responsible for 
the interaction between PKR and STAT3, a GST 
pull-down  assay  was  performed,  using  different 
truncated GST-PKR. As shown in figures 7C, 7D, 
and 7E, only full-length PKR, and not the control 
GST, GST-PKR 1-265 aa, GST-PKR 1-180 aa, or 
GST-PKR 265-551 aa pulled down with STAT3 and 
p-STAT3 in different cell lines (Huh-7, replicon) with 
and without INF-α stimulation. The result suggests 
that the binding between PKR and STAT3 might 
depend on the conformation of PKR. The binding 
intensity of PKR and STAT3 and the domain of 
PKR between Huh-7 and replicon with and without 
INF-α  stimulation  was  almost  identical,  which 
suggests that the PKR and STAT3 binding might 
also  be  independent  of  HCV.  When  performing 
the PKR and p-STAT3 GST pull-down assay, we 
found that p-STAT3 was higher bound with PKR 
than STAT3 both in Huh-7 and replicon with and 
without  INF-α  stimulation,  which  indicates  that 
PKR might induce STAT3 phosphorylation and that 
direct interaction between PKR and STAT3 might 
increase the activation of STAT3.
Figure 5. HCV Core physically interacts with STAT3: Whole cell lysates 
(500 μg) from Huh-7 (H: lane 1, 3, 5), replicon cells (R: lane 2, 4, 
6) were used for immunoprecipitation with polyclonal anti-STAT3 (Santa 
Cruz). Immunoprecipitates were separated by SDS-PAGE and transfered to 
nitrocellulor membranes and immunoblotted with anti-STAT3 (upper panel) 
and anti-Core (lower panel). Lane 1, 2: protein G without antibody served 
as negative control. Lane 5, 6: 1/10 input (50 μg of cell protein).
Figure 4. STAT3 and p-STAT3 expression in different cells: 
Huh-7: 1-2; replicon: lane 3-4; Huh-7 transfected with HCV 
Core from C191 with 1 and 2 ug of plasmids respectively 
lane 5-6. 2, 4 was stimulated with IFN-α 500 IU/ml for 18 
hours; lane 1, 3, 5, 6 without IFN-α stimulation.Hepat Mon. 2010; 10(4): 275-284
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Disscusion 
HCV  Core  has  been  extensively  studied  and 
appears  to  play  multiple  roles  in  various  cellular 
signaling pathways, potentially even in oncogenesis. 
Different domains of HCV Core might have various 
functions (15). Versatile functions of HCV Core have 
been mapped to its N-terminal half. HCV Core is 
hydrophilic and contains clusters of basic aa residues, 
which serve as putative localization signals (NLS) as 
well as binding domains for RNA and ribosome (16). 
Moreover, the N-terminal region of HCV Core has 
been shown to be involved in its multimerization, 
transcriptional  regulation,  and  interaction  with 
certain cellular factors, including lymphotoxin-beta 
receptor, heterognous nuclear ribonucleo-protein K, 
and  RNA  helicase  (17-20).  We  found  that  the 
interaction between HCV Core and PKR depended 
on N-terminal 1-58 aa of HCV Core and N-terminal 
1-180  aa  of  PKR  (12),  which  might  increase  the 
translocation of PKR from cytopalsmic to nuclear. It 
is  possible  that,  in  HCV-infected  individuals, 
different  truncated  HCV  Core  might  exist,  with 
shorter HCV Core, more in the nuclear region. Our 
findings confirm the results of another recent study, 
which found that nuclear HCV Core facilitated the 
translocation of PKR into nucleoli where the two 
proteins  colocalized  are  suggestive  of  a  direct 
interaction between truncated HCV Core and PKR. 
Nucleolar translocation of PKR might indeed reflect 
its  activation  (21).  In  this  work,  we  further 
demonstrated  that  N-terminal  1-126  aa  of  HCV 
Core can directly bind to STAT3. The HCV genome 




Figure 6. The N-terminus of Core (aa 1-126) is involved in the interaction 
with STAT3 A: In order to verify in each GST pull-down assay reaction 
system approximately equal amount of GST-Core was used, 1 μg of 
different truncated GST-Core was used to do Coomassie Blue Staining. 
M: marker; Lane 1: GST, Lane 2-6: different truncated GST-Core of 
BT; Lane 7: BNT; Lane 8: C191. Arrow stands for target bands. B, C: 
Control GST (lane 1) and GST fused to different truncated  Core (lanes 
3 to 8) were incubated in the presence of in vitro expressed STAT3 
and p-STAT3 in different cells(replicon, Huh-7) (lanes 2- 8). Lane 9, 50% 
input ( 60 μg of total protein).Hepat Mon. 2010; 10(4): 275-284
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currently classified into 6 genotypes and more than 
60 subtypes  (22, 23). Even with the same subtype, 
there exist quasi-species. Quasi-species constitute a 
pool of viral variants that can change and acquire 
new selective advantages in a very short time; thus, 
these new variants have adaptive advantages with a 
modified viral tropism, host range, virulence, and 
drug  resistance.  Therefore,  Patients  infected  with 
different HCV genotypes might have unique clinical 
features  (24), and different HCV genotypes might 
contribute some of their own characteristics in the 
pathogenesis. HCV Core could induce the expression 
of STAT3, and HCV Core from BT, BNT and C191 
(they all belong to HCV genotype 1b) in vitro can 
bind to STAT3. Furthermore, only HCV Core from 
BT could bind to p-STAT3, which might be one of 
the  characteristics  of  HCV  genotype  1b  in  its 
pathogenesis, or at least one pathogenesis characteristic 
of some HCV genotype 1b strains, and which might 
account  for  why  incidences  of  liver  cirrhosis  and 
HCC are higher in HCV genotype 1b than those of 
other genotypes. Because we did not construct HCV 
Core expression plasmids of other HCV genotypes, 
so we cannot generalize our conclusion to all other 
HCV  genotypes.  However,  HCV  Core  encoding 
genome  among  different  genotypes  is  highly 
conserved.  Comparing  the  nucleotide  and  aa 
sequences of BT, BNT, and C191, they contain high 
homology at aa and nucleotide levels (6). Additionally, 
BT did not contain a specific motif; therefore, the 
interaction between HCV Core and STAT3 might 





Figure 7. GST pull-down assay among HCV Core, PKR, STAT3 and p-STAT3. In Replicon and Huh-
7 cells, GST-Core 1-172 aa (A: lane 2) and GST-PKR 1-551 aa (A: lane 3) could bind with STAT3. 
GST-PKR (B: lane 3; D, E: lane 2) could bind with p-STAT3 but not the GST-Core. Only full-length of 
GST-PKR (1-551)(C, D, E: lane 2) bound with STAT3 and p-STAT3 both in Huh-7 and replicon cells 
with or without IFN-α stimulation.Hepat Mon. 2010; 10(4): 275-284
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heterologous overexpression of HCV structural and 
nonstructural proteins may have stronger oncogenic 
potential  than  the  expression  of  individual  viral 
proteins (25). STAT3 activation can also occur with 
HCV Core and with the expression of whole HCV 
proteins. Recently, a study noted a similar constitutive 
activation  of  STAT3  by  the  nonstructural  HCV 
protein NS5A (26). But in another study, no effects of 
these  agents  on  HCV-Core-mediated  STAT3 
activation was observed (8). Transcriptional activity 
of STAT3 was also more strongly up-regulated by the 
full HCV genome than by HCV Core alone (8). In 
our study, it is interesting that HCV Core alone more 
strongly induced STAT3 as compared with the whole 
HCV genome expression. This suggests that STAT3 
may be induced and activated by multiple mechanisms 
and  by  different  viral  proteins.  Further  study  is 
needed to define the relationship between STAT3 
activation,  transformation,  and  full  HCV  protein 
expression. HCV Core cooperates with STAT3 in 
malignant transformation as other viral oncoproteins 
or cellular protooncogenes do, thereby contributing 
to  malignant  transformation.  As  cells  expressing 
HCV  Core  alone  were  not  tumorigenic,  for  the 
appearance of HCC, some secondary “hit(s),” such 
as elevated expression of STAT3 or activation of ras 
(27),  must  be  necessary  for  the  development  of  a 
malignant phenotype. Up-regulation of cyclin D1, 
C-myc,  and  Bcl-XL  may  explain  the  increase  in 
growth rate by activation of STAT3 (28, 29), yet these 
two genes are not sufficient for cellular transformation. 
Yoshikawa  and  colleagues  reported  evidence  that 
inactivation of SOCS1 by gene methylation and the 
consequent constitutive activation of cytokine-JAK/
STAT  (especially  STAT3)  signaling  pathways  are 
responsible  for  growth  of  HCCs  (30).  Given  that 
Core  expression  occurred  only  in  the  presence  of 
HCV  (the  HCV  genome  is  not  integrated  into 
hepatocyte  DNA),  the  interaction  between  HCV 
Core and STAT3 may be an initial step of STAT3 
activation, and then the loss of SOCS-1 expression 
takes over the constitutive activation of STAT3 (30). 
Therefore,  the  constitutive  activation  of  STAT3 
induced by viral or cellular oncogenes or the loss of 
suppressors  present  an  attractive  target  for  drug 
discovery with the potential of inducing cell death or 
inhibiting  the  growth  of  human  HCV-mediated 
hepatocarcinomas. In this study, we found that PKR 
bound with STAT3 and that only full-length PKR 
could interact with STAT3, which might depend on 
the conformation of PKR. The PKR/STAT3 binding 
intensity and domain of PKR between Huh-7 and 
replicon, and between PKR with and without IFN-α 
stimulation is almost the same, which suggests that 
the interaction between PKR and STAT3 might also 
be  HCV  independent.  Based  on  our  study,  we 
proposed two models about the associations of HCV 
Core, PKR, and STAT3. Model 1 (as shown in Figure 
8A) indicates that all 3 molecules can interact with 
each  other.  HCV  Core  plays  its  role  mainly  by 
interacting with cellular proteins. HCV Core, PKR 
and STAT3 might all interact together, or HCV Core 
might affect cell proliferation through both PKR and 
STAT3. It is possible that the physical association of 
these molecules modulates their respective activates. 
Two mechanisms may account for their interactions. 
First,  heterodimerization  could  confer  unique 
properties on either STAT3 or HCV Core at the level 
of  protein  stabilization  or  cellular  localization. 
Second,  because  the  HCV  Core  protein  has  no 
tyrosine  kinase  activity  (17),  the  binding  between 
HCV  Core,  PKR  and  STAT3  might  hamper  the 
phosphatases  approach  to  STAT3  and  PKR  or 
directly block the phosphatic site of STAT3 and PKR 
and HCV Core, which eventually would cause their 
constitutive expression and activiation. HCV Core 
can induce expression of STAT3 and p-eIF-a and 
bind to STAT3 and some quasi-species, and HCV 
Figure 8.  Models of interactions among HCV Core, PKR and STAT3. 
Model one: HCV Core, PKR and STAT3 can physically directly interact 
with each other and might form a ternary complex. Model two: HCV 
Core plays its function through both of PKR and STAT3 but mainly 
through PKR, HCV Core binding to STAT3 and activating STAT3 might 
be due to interaction or activation of Core/ PKR.Hepat Mon. 2010; 10(4): 275-284
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Core can also bind to p-STAT3. It remains unclear 
whether HCV Core can directly bind to and inhibit 
the  phosphorylation  of  STAT3  and  PKR.  The 
manner in which HCV Core induces the tyrosine 
phosphorylation of STAT3 and PKR is also unclear. 
Another possibility is that the interaction between 
HCV Core and STAT3 can recruit a tyrosine kinase 
to STAT3. As for model 2 (Figure 8B), HCV Core’s 
binding to STAT3 or activation of STAT3 might be 
due to the interaction between or activation of HCV 
Core  and  PKR.  In  other  words,  the  interaction 
between HCV Core and PKR might activate and 
increase  the  activity  of  PKR  (6,  12),  which  would 
inhibit HCV replication and increase cell apoptosis. 
PKR, as a protein (14), can act as a mediator and link 
other  proteins.  PKR  can  also  act  as  an  adaptor, 
recruiting STAT kinases through its preassociation 
with STAT3. Additionally, PKR is necessary for the 
phosphorylation of STAT3 (11, 31, 32), allowing for a 
rapid response to various stimuli. Several oncogenic 
proteins, including HCV Core, have been reported 
to activate STAT3, which might occur through PKR. 
HCV Core binds to PKR, although the interaction 
between HCV Core and PKR might induce other 
pathways, such as an interaction between PKR and 
STAT3 or an interaction between HCV Core and 
STAT3. PKR, as a kinase, can phosphorylate other 
proteins, including STAT3. Constitutive expressed 
PKR, by phosphorylation of C-jun to suppress the 
cell  reaction  to  TGF-ß  (33),  leads  to  vicious  cell 
generation. At the same time, PKR can act as an up-
regulator in the activation of STAT3, resulting in the 
rapid  overproliferation  and  vicious  malignancy 
transformation of cells, and as a common mediator 
of  both  growth-promoting  and  growth-inhibitory 
signals. It is possible that the elevated levels of PKR 
result in STAT3 misregulation, even though HCV-
Core-induced  apoptosis  of  infected  hepatocytes 
through  PKR  may  be  important  in  virion 
dissemination and in liver damage during chronic 
infection. It has been proposed that the proapoptotic 
effect  of  HCV  Core  could  contribute  to  the 
development  of  HCC  by  promoting  continuous 
regeneration of hepatic cells (21, 34, 35). Although we 
have not been able to demonstrate a significant effect 
of the interactions between HCV Core, PKR, and 
STAT3 on cell growth, it is possible that cells resistant 
to  HCV-Core-mediated  apoptosis  could  have 
enhanced  growth  and  a  replicative  cycle.  This 
explanation is consistent with the demonstration of 
an  accelerated  cell  cycle  coexisting  with  apoptosis 
induction in cell clones expressing HCV Core (36, 
37).  We  are  not  able  to  simply  generalize  our 
conclusions  to  physiological  infection  conditions. 
Therefore, confirmation of our hypothesis by using 
human specimens infected with HCV is necessary in 
future studies. Howe ever, this study raises a plausible 
mechanisms to explain interactions between HCV 
Core, PKR, and STAT3 and provides new insight 
into  the  mechanisms  of  HCV-persistent  infection 
and HCC development. Finally, the study adds a 
new aspect of virological function of HCV Core. 
The two models might represent another viral and 
cellular protein interaction and might pave the way 
to finding a new therapy for HCV.
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